» Articles » PMID: 36768978

Phytochemicals As Immunomodulatory Agents in Melanoma

Abstract

Cutaneous melanoma is an immunogenic highly heterogenic tumor characterized by poor outcomes when it is diagnosed late. Therefore, immunotherapy in combination with other anti-proliferative approaches is among the most effective weapons to control its growth and metastatic dissemination. Recently, a large amount of published reports indicate the interest of researchers and clinicians about plant secondary metabolites as potentially useful therapeutic tools due to their lower presence of side effects coupled with their high potency and efficacy. Published evidence was reported in most cases through in vitro studies but also, with a growing body of evidence, through in vivo investigations. Our aim was, therefore, to review the published studies focused on the most interesting phytochemicals whose immunomodulatory activities and/or mechanisms of actions were demonstrated and applied to melanoma models.

Citing Articles

Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges.

Gajos-Michniewicz A, Czyz M Int J Mol Sci. 2024; 25(23).

PMID: 39684513 PMC: 11641450. DOI: 10.3390/ijms252312804.


Extract of Araçá-Boi and Its Major Phenolic Compound, Trans-Cinnamic Acid, Reduce Viability and Inhibit Migration of Human Metastatic Melanoma Cells.

Tecchio Borsoi F, da Silva G, Manica D, Bagatini M, Pastore G, Arruda H Nutrients. 2024; 16(17).

PMID: 39275245 PMC: 11396791. DOI: 10.3390/nu16172929.


Natural Sunlight-Mediated Emodin Photoinactivation of .

Urgesa G, Lu L, Gao J, Guo L, Qin T, Liu B Int J Mol Sci. 2024; 25(10).

PMID: 38791482 PMC: 11121522. DOI: 10.3390/ijms25105444.


Immunomodulation of Skin Cancer.

Yusuf N Int J Mol Sci. 2023; 24(13).

PMID: 37445639 PMC: 10341904. DOI: 10.3390/ijms241310462.


Blume Essential Oil Inhibits Metastatic Melanoma Cell Proliferation by Triggering an Incomplete Tumour Cell Stress Response.

Cappelli G, Giovannini D, Vilardo L, Basso A, Iannetti I, Massa M Int J Mol Sci. 2023; 24(6).

PMID: 36982774 PMC: 10058067. DOI: 10.3390/ijms24065698.

References
1.
Tabolacci C, Cordella M, Rossi S, Bonaccio M, Eramo A, Mischiati C . Targeting Melanoma-Initiating Cells by Caffeine: In Silico and In Vitro Approaches. Molecules. 2021; 26(12). PMC: 8231844. DOI: 10.3390/molecules26123619. View

2.
Tawbi H, Schadendorf D, Lipson E, Ascierto P, Matamala L, Castillo Gutierrez E . Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. N Engl J Med. 2022; 386(1):24-34. PMC: 9844513. DOI: 10.1056/NEJMoa2109970. View

3.
Menon L, Ingle A, Gude R . Tumor regression of B16F10 melanoma in vivo by prevention of neovascularization: study on theophylline. Cancer Biother Radiopharm. 2002; 17(2):213-7. DOI: 10.1089/108497802753773838. View

4.
Lian G, Wang Q, Mak T, Huang X, Yu X, Lan H . Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin. Mol Ther Oncolytics. 2021; 20:277-289. PMC: 7873580. DOI: 10.1016/j.omto.2021.01.006. View

5.
Tang Y, Cao Y . Curcumin Inhibits the Growth and Metastasis of Melanoma via miR-222-3p/SOX10/Notch Axis. Dis Markers. 2022; 2022:3129781. PMC: 9110126. DOI: 10.1155/2022/3129781. View